Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-03-26

FDA Approved: LEVETIRACETAM — Supplemental Application (Dr.Reddy's Laboratories Inc)

View source ↗

Summary

FDA approved a supplemental application for LEVETIRACETAM INJECTION by Dr. Reddy's Laboratories, adding an injectable formulation of levetiracetam for epilepsy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LEVETIRACETAM INJECTION (LEVETIRACETAM)

Snippet

SUPPL AP for LEVETIRACETAM (LEVETIRACETAM INJECTION)